Home
About
Our Beginning
Projects
Partners
Contact
Our Blog
News and Media
Events
Projects We Fund
Gallery
Donate
New Products

The Gregory Foundation for Cancer Research

Home
About
Our Beginning
Projects
Partners
Contact
Our Blog
News and Media
Events
Projects We Fund
Gallery
Donate
New Products
Roshan Mathai
May 18, 2018

An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 2017.

Roshan Mathai
May 18, 2018

Source:https://www.ncbi.nlm.nih.gov/pubmed/28678778

Newer PostCancer-killing viruses show promise
Older PostGenomic analysis unravels complexities of the most common form of lymphoma and enables personalized treatment.
Back to Top

Powered by Squarespace